Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up ...

Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

PharmAla Biotech Holdings Inc. ("PharmAla” or the "Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...

Philippe Masset has been appointed to the Board of Directors at Vect-Horus, a French biotech developing vectors for targeting ...

PepGen to focus on development of DM1 programme following 10 mg/kg PGN-EDO51 update: Boston Friday, May 30, 2025, 14:00 Hrs [IST] PepGen Inc, a clinical-stage biotechnology compan ...